For children with established AD and food allergies, early systemic therapy, including dupilumab and JAK inhibitors, may interrupt progression along the atopic march, with data supporting both ...
Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...
Participants in the combined treatment group lost significantly more weight at 3, 6, and 12 months and were more likely to lose 5%, 10%, or >15% of their body weight at 12 months compared with DELI al ...
The "AI-based Clinical Trials Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The AI-based clinical trials market is driving a fundamental transformation in ...
Milliman MedInsight (R) (MedInsight), a leading healthcare data and analytics division of Milliman, is entering 2026 with accelerating momentum in value-based care. Milliman MedInsight has earned ...
Top workflow pain points frustrating physicians include documentation burden, chart review overload, inbox volume, and fragmented digital tools.
Ardent Health cut low-value care using clinical decision support, achieving $97 savings per admission and rapid provider adoption in 90 days.
In today's healthcare environment, securing regulatory approval is only the beginning. The real challenge lies in ensuring ...
Metabolic dysfunction-associated steatotic liver disease (MASLD) is now the most common chronic liver disease in the Western world, driven by obesity, insulin resistance, and systemic inflammation.
Advances in biomarker-driven and individualized approaches in neurology and psychiatry will require new frameworks for value ...
Corvus Pharmaceuticals, Inc. jumps 165% on Phase 1 soquelitinib atopic dermatitis data; learn key efficacy, funding, and ...
MINNEAPOLIS, MN, UNITED STATES, January 20, 2026 /EINPresswire.com/ -- Itiliti Health, a leader in prior authorization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results